These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9417556)

  • 21. Implanted automatic defibrillators: effects of drugs and pacemakers.
    Singer I; Guarnieri T; Kupersmith J
    Pacing Clin Electrophysiol; 1988 Dec; 11(12):2250-62. PubMed ID: 2463613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pacing threshold increase in nonthoracotomy implantable defibrillator leads: implications for battery longevity and margin of safety.
    Epstein AE; Plumb VJ; Kirk KA; Kay GN
    J Interv Card Electrophysiol; 1997 Sep; 1(2):131-4. PubMed ID: 9869961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Leadless pacemakers and subcutaneously implantable cardioverter defibrillators].
    Stellbrink C; Hansky B; Meyer Zu Vilsendorf D
    Internist (Berl); 2018 Oct; 59(10):999-1010. PubMed ID: 30105398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causes and Prevention of Inappropriate Implantable Cardioverter-Defibrillator Shocks.
    Kulkarni N; Link MS
    Card Electrophysiol Clin; 2018 Mar; 10(1):67-74. PubMed ID: 29428143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinical practice guidelines of the Sociedad Española de Cardiología on the automatic implantable defibrillator].
    Pérez-Villacastín J; Carmona Salinas JR; Hernández Madrid A; Marín Huerta E; Merino Llorens JL; Ormaetxe Merodio J; Moya i Mitjans A
    Rev Esp Cardiol; 1999 Dec; 52(12):1083-104. PubMed ID: 10659655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of device therapy for ventricular arrhythmias.
    Holley LK
    Heart Lung Circ; 2007 Jun; 16(3):162-9. PubMed ID: 17446124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients.
    Zangger G; Zwisler AD; Kikkenborg Berg S; Kristensen MS; Grønset CN; Uddin J; Pedersen SS; Oldridge NB; Thygesen LC
    Eur J Prev Cardiol; 2018 Jan; 25(2):142-149. PubMed ID: 28952795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The implantable cardioverter defibrillator.
    Glikson M; Friedman PA
    Lancet; 2001 Apr; 357(9262):1107-17. PubMed ID: 11297981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A life-threatening arrhythmia induced by inappropriate activation of an implantable cardioverter defibrillator.
    Kadmon E; Kusniec J; Strasberg B
    Europace; 2009 Dec; 11(12):1716-8. PubMed ID: 19762330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automatic implantable cardioverter-defibrillator structural characteristics.
    Mower MM; Reid PR; Watkins L; Griffith LS; Platia EV; Bach SM; Imran M; Juanteguy JM; Mirowski M
    Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 2):1331-7. PubMed ID: 6209679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; Mcguire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S;
    Europace; 2016 Feb; 18(2):159-83. PubMed ID: 26585598
    [No Abstract]   [Full Text] [Related]  

  • 33. Implantable cardioverter defibrillators: a guide for clinicians.
    Davidson T; VanRiper S; Harper P; Wenk A
    Heart Lung; 1994; 23(3):205-15; quiz 216-7. PubMed ID: 8039991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Troubleshooting implantable cardioverter-defibrillator sensing problems II.
    Swerdlow CD; Asirvatham SJ; Ellenbogen KA; Friedman PA
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):212-20. PubMed ID: 25691555
    [No Abstract]   [Full Text] [Related]  

  • 36. The wearable cardioverter-defibrillator: current technology and evolving indications.
    Reek S; Burri H; Roberts PR; Perings C; Epstein AE; Klein HU; ; Lip G; Gorenek B; Sticherling C; Fauchier L; Goette A; Jung W; Vos MA; Brignole M; Elsner C; Dan GA; Marin F; Boriani G; Lane D; Blomström-Lundqvist C; Savelieva I
    Europace; 2017 Mar; 19(3):335-345. PubMed ID: 27702851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter-defibrillators.
    Pinski SL; Fahy GJ
    Am J Med; 1999 Apr; 106(4):446-58. PubMed ID: 10225249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias.
    Kay GN; Plumb VJ; Dailey SM; Epstein AE
    Am J Med; 1990 Jan; 88(1N):25N-34N. PubMed ID: 2195882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.